MENINGOCOCCAL POLYSACCHARIDE VACCINE PF - SUBCUTANEOUS INJECTION

MENINGOCOCCAL POLYSACCHARIDE VACCINE PF - SUBCUTANEOUS INJECTION

PHONETIC PRONUNCIATION:

COMMON BRAND NAME(S): MENOMUNE-A/C/Y/W-135

GENERIC NAME(S): Meningococcal Vaccine A,C,Y,W-135/PF

Uses

USES: This vaccine helps to protect high-risk patients against a certain type of serious bacterial infection that affects the brain and spinal cord (meningitis). This medication is also used to control an outbreak of this infection if it occurs. This vaccine does not protect you against all strains of this type of bacteria. Vaccines work by causing the body to produce its own protection (antibodies). Enough antibodies to protect you are usually produced within 7-10 days after you receive this vaccine.


How to use MENINGOCOCCAL POLYSACCHARIDE VACCINE PF - SUBCUTANEOUS INJECTION

HOW TO USE: Read all vaccine information available from your health care professional before receiving the vaccine. If you have any questions, ask your health care professional. This vaccine is given by injection only under the skin (subcutaneously) by a health care professional. You may need to have another dose of vaccine if you are still at high risk for infection 2-3 years after your last shot. Ask your health care professional for more details. This vaccine can be given at the same time as most other vaccines, using separate injection sites and separate syringes. However, it must not be given at the same time as whole-cell pertussis or typhoid vaccines.

Side Effects

SIDE EFFECTS: Pain, redness, swelling, and tenderness at the injection site commonly occur and usually last 1-2 days. Headache and fever may also occur. Ask your health care professional if you should take a fever/pain reducer (e.g., acetaminophen) to help treat these symptoms. If any of these effects persist or worsen, notify your health care professional promptly. Remember that your health care professional has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your health care professional. Contact the health care professional for medical advice about side effects. The following numbers do not provide medical advice, but in the US you may report side effects to the Vaccine Adverse Event Reporting System (VAERS) at 1-800-822-7967. In Canada, you may call the Vaccine Safety Section at Public Health Agency of Canada at 1-866-844-0018.

Precautions

PRECAUTIONS: See also How to Use and Drug Interactions sections. Before receiving this vaccine, tell your health care professional if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients (such as latex or dry natural rubber that can be found in the vial stopper), which can cause allergic reactions or other problems. Talk to your health care professional for more details. Before you receive this vaccine, tell the health care professional your medical history, especially of: your vaccination/immunization history, recent illness or fever, immune system problems (e.g., due to cancer treatment, organ transplant, HIV). This vaccine should be used only when clearly needed during pregnancy. Discuss the risks and benefits with your health care professional. It is unknown if this vaccine passes into breast milk. Consult your health care professional before breast-feeding.

Interactions

DRUG INTERACTIONS: Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your health care professional. Do not start, stop, or change the dosage of any medicines without your doctor's approval. Some products that may interact with this vaccine include: cancer chemotherapy drugs, corticosteroids (e.g., dexamethasone, prednisone), drugs that weaken your immune system (e.g., cyclosporine, tacrolimus), whole-cell pertussis or typhoid vaccines.

Overdose

OVERDOSE: Not applicable.

Images

Reviews

No Reviews Yet


Faq for MENINGOCOCCAL POLYSACCHARIDE VACCINE PF - SUBCUTANEOUS INJECTION

Meningococcal Polysaccharide Vaccine PF is a vaccine that helps protect against infections caused by the bacteria Neisseria meningitidis, which can lead to meningococcal disease.

Meningococcal Polysaccharide Vaccine PF is given as a subcutaneous injection, which means it is injected just beneath the skin.

Meningococcal Polysaccharide Vaccine PF is typically recommended for individuals between the ages of 2 and 55 years old who are at increased risk of meningococcal disease, such as college students living in dorms, military recruits, and travelers to certain countries.

Usually, a single dose of Meningococcal Polysaccharide Vaccine PF provides adequate protection. However, some individuals at high risk may require additional booster doses.

Common side effects of Meningococcal Polysaccharide Vaccine PF include pain, redness, or swelling at the injection site, as well as fever, headache, and fatigue. Serious side effects are rare.

The duration of protection provided by Meningococcal Polysaccharide Vaccine PF varies. It may provide immunity for a few years, but it is generally not long-lasting.

Yes, Meningococcal Polysaccharide Vaccine PF can be administered at the same time as other vaccines. However, it is always best to consult with a healthcare professional to ensure proper vaccination scheduling.

Meningococcal Polysaccharide Vaccine PF is considered safe and well-tolerated. Like any vaccine, it may have some side effects, but serious complications are extremely rare.

Pregnant women should consult with their healthcare provider before receiving Meningococcal Polysaccharide Vaccine PF. The decision to immunize during pregnancy should be made on a case-by-case basis, considering the potential benefits and risks.



Disclaimer

IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.